Edition:
United States

Edwards Lifesciences Corp (EW)

EW on New York Consolidated

176.87USD
19 Feb 2019
Change (% chg)

$-0.91 (-0.51%)
Prev Close
$177.78
Open
$177.80
Day's High
$178.68
Day's Low
$176.51
Volume
274,009
Avg. Vol
1,507,433
52-wk High
$178.68
52-wk Low
$123.00

Chart for

About

Edwards Lifesciences Corporation is a manufacturer of heart valve systems and repair products used to replace or repair a patient's diseased or defective heart valve. The Company is engaged in patient-focused innovations for structural heart disease and critical care monitoring. Its segments include United States, Europe, Japan... (more)

Overall

Beta: 0.92
Market Cap(Mil.): $36,936.70
Shares Outstanding(Mil.): 207.77
Dividend: --
Yield (%): --

Financials

  EW Industry Sector
P/E (TTM): 54.75 69.36 36.06
EPS (TTM): 3.25 -- --
ROI: 15.99 6.23 12.72
ROE: 22.80 8.77 13.74

Edwards Lifesciences beats on revenue but forecast lags estimates

U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter earnings fell below analysts' forecasts.

Jan 31 2019

Edwards Lifesciences beats on revenue but forecast lags estimates

Jan 31 U.S. medical device maker Edwards Lifesciences narrowly topped Wall Street estimates for quarterly revenue on Thursday as it sold more heart monitors, but its outlook for March quarter earnings fell below analysts' forecasts.

Jan 31 2019

Chinese man gets prison for stealing trade secrets from ev3, Edwards

A Chinese man who worked at medical device manufacturers ev3 Inc and Edwards Lifesciences Corp has been sentenced to 27 months in prison for stealing trade secrets from them in order to make products at a company that had Chinese government funding.

Jan 29 2019

Edward Lifesciences pays Boston Scientific $180 million to end patent row

Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Jan 15 2019

UPDATE 2-Edward Lifesciences pays Boston Scientific $180 mln to end patent row

Jan 15 Edwards Lifesciences Corp has paid rival Boston Scientific Corp $180 million as part of a settlement to end long-standing patent disputes between the two medical device makers.

Jan 15 2019

Edwards owes Boston Scientific $35 mln in heart valve patent case - jury

A federal jury in Delaware has ordered medical device maker Edwards Lifesciences Corp to pay $35 million after finding a heart valve replacement system it makes infringes a patent held by rival Boston Scientific Corp.

Dec 12 2018

UPDATE 2-Surgical product sales drive Boston Scientific's profit beat

* Co tightens EPS forecast on foreign exchange headwinds (Adds details from conference call, analyst comment; Updates shares)

Oct 24 2018

Earnings vs. Estimates